[May 24, 2012] Maxygen Shares Up 60.5% Since SmarTrend's Buy Recommendation (MAXY) Tweet May 24, 2012 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Maxygen (NASDAQ:MAXY) on August 2nd, 2010 at $3.62. In approximately 22 months, Maxygen has returned 60.50% as of today's recent price of $5.81. Maxygen share prices have moved between a 52-week high of $6.20 and a 52-week low of $4.99 and are now trading 16% above that low price at $5.81 per share. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.3%. Maxygen, Inc. is a biopharmaceutical company which researches and develops protein drugs. The Company's products now in clinical trials include an interferon alpha for treating Hepatitis C, and a G-CSF for treating neutropenia. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Maxygen shares.Log in and add Maxygen (MAXY) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]